CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity.
about
Human STX polysialyltransferase forms the embryonic form of the neural cell adhesion molecule. Tissue-specific expression, neurite outgrowth, and chromosomal localization in comparison with another polysialyltransferase, PSTCytogenetic abnormalities in natural killer cell lymphoma/leukaemia--is there a consistent pattern?Acute lymphoblastic leukemia with coexpression of CD56 and CD57: case reportT-cell lymphomas, a challenging disease: types, treatments, and future.Aggressive NK cell lymphoma preceded by a ten year history of neutropenia associated with large granular lymphocyte lymphocytosis.Sinonasal malignant lymphomas: a distinct clinicopathological category.Natural killer cell lymphoma: report of two pediatric cases, therapeutic options, and review of the literature.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsMost CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.Consistent patterns of allelic loss in natural killer cell lymphoma.Natural killer-cell malignancies: diagnosis and treatment.Nasal-type NK/T cell lymphoma: clinical features and treatment outcome.Diagnosis and management of natural killer-cell malignancies.Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.NCAM (CD56)-positive malignant lymphoma.CD56 (NCAM)-positive malignant lymphoma.CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. Report of two cases and review of the literature.Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection.Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection.Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma.Epstein-Barr virus and T-cell lymphoma.Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.Aleukaemic leukaemia cutis as an initial manifestation of myeloid/NK cell precursor acute leukaemia.EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia.NK-cell neoplasms in Japan.A case of CD56+ cutaneous aleukaemic granulocytic sarcoma with myelodysplastic syndrome.Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.Subcutaneous panniculitis-like T-cell lymphoma: further evidence for a distinct neoplasm originating from large granular lymphocytes of T/NK phenotype.Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1.
P2860
Q24324255-52A31D7C-F401-418D-AD0A-3EF0C672C7FAQ28141563-8B19E565-5393-4A00-A85B-047E93C6FB72Q28300657-444B3337-6ADC-49A3-B57E-66316AC613F6Q30244553-E2C8B685-251A-46C8-9E9B-195503E01633Q33504780-107F09D2-36F9-4110-884D-D85444ED55A9Q33600958-6D093C7C-EEF7-4EAE-911D-25FC88FF7A75Q34176383-F7573DBC-23AD-4839-A3F8-9A3482342BA0Q35232848-21B39976-C933-4362-B6AF-DD6CBDFF7BEAQ35754515-2A6CE91F-C1F1-4ECF-B08B-AF30DC45FAEEQ35788068-358A934F-8D47-4CD0-954D-531AE8BAF72EQ35829661-191AEC12-6FFB-4061-A12B-34B075EAAB48Q36265596-52180B10-05F4-40F8-AC22-E8792EB5AE01Q36616654-ED61EC83-B015-47FB-89E5-5DDD4880EF4AQ37810280-442EDA95-16AD-4287-B1D3-EF8E21A068D8Q38043974-82846E4E-D75A-4C77-A4D0-66DBCDDE6DF0Q38526421-DDB9F770-DB5C-415C-AAAA-59DD37466E3DQ39284101-DED0362A-7777-4E39-AC4B-7F8EB636CD8DQ40181184-C65657C9-C8DA-445B-ADE2-F15C944CB5A1Q40388157-56E4A58C-68D3-4DA7-A493-E578CCDC9D4BQ40392966-CB6B5AF1-9665-4A8E-8482-CA4F7666414CQ41613539-945A1CA7-7674-4F99-9651-A00D37326852Q42049633-F6EEED16-A70C-4FE6-B28D-9D75392044FEQ44140162-11DFD1EF-CB81-434E-9E56-4D8FA210DF86Q45740408-8E24DB76-26AD-47B2-931A-263766A9B4C4Q45766542-66B0F44A-1152-4F51-8ED5-22746FACCD7AQ45783913-7734EC0C-A08D-47A9-BBCC-4DAE2BD1C8A2Q48726210-00BFB82E-FE16-4E3A-8FDF-290BDE583FDAQ50736161-A06C9AB9-E874-4CC3-AD4E-9DEA9BD6A74CQ51735191-4DB1FAA4-7E66-4928-9961-14A4AC3D91F8Q52845594-EEC83E41-B89D-4F80-B694-E5832897AB0FQ53233763-33E04790-E240-488F-9ED2-7892A3FDD13DQ53270482-232ABE22-6B3B-4537-8E4E-56E8E5A7AB49Q53406126-9BCBFB3D-78BF-49DD-B116-0C555E55E2C6Q54127311-7D5479DB-BFA6-40AC-BE1F-D9DC7EE3F5F4Q54273797-5D0C8D92-2758-4785-A2F5-74BBFC20FFF7Q55240318-F33167B4-FF60-4D71-9F9F-70E005C077F5
P2860
CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
CD56 (NKH1)-positive hematolym ...... granules, and angiocentricity.
@en
type
label
CD56 (NKH1)-positive hematolym ...... granules, and angiocentricity.
@en
prefLabel
CD56 (NKH1)-positive hematolym ...... granules, and angiocentricity.
@en
P2093
P1433
P1476
CD56 (NKH1)-positive hematolym ...... granules, and angiocentricity.
@en
P2093
P304
P356
10.1016/0046-8177(92)90350-C
P407
P577
1992-07-01T00:00:00Z